Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Bertin

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Neuropharmacology|March 15, 2017
RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodentsKhadija Elhabazi, Jean-Paul Humbert, Isabelle Bertin, et al.
Blood Transfusion = Trasfusione Del Sangue|March 16, 2026
Results of red cell antibody screening assays from 2,500 laboratories in 10 external quality assessment programs: sensitivity for anti-DChristoph Buchta, Willy A Flegel, Wim Coucke, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Neuropharmacology|March 15, 2017
RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodentsKhadija Elhabazi, Jean-Paul Humbert, Isabelle Bertin, et al.
Blood Transfusion = Trasfusione Del Sangue|March 16, 2026
Results of red cell antibody screening assays from 2,500 laboratories in 10 external quality assessment programs: sensitivity for anti-DChristoph Buchta, Willy A Flegel, Wim Coucke, et al.
Pageof 3